Tianjin Zhongrui Pharmaceutical Co., Ltd.（天津中瑞药业股份有限公司）

Tianjin Zhongrui Pharmaceutical was founded in March 2004 with registered capital of RMB 26 million and produces chemical active pharmaceutical ingredients, pharmaceutical excipients and food additives. Its principal products are niacin and nicotinamide, which cover the nicotinic acid and vitamin B3 listed here, together with inositol nicotinate, terazosin hydrochloride, clopidogrel bisulfate, fasudil hydrochloride and dopamine hydrochloride. All of these hold GMP certificates, and the company registers its output under the Jinrui trademark.

The site covers 21,000 square metres with more than 4,000 square metres of buildings, made up of an R&D centre, a quality analysis centre, an office building, production workshops and warehouses. Headcount is 111, of whom 32 are technical staff: five with senior titles, ten with intermediate titles, two licensed pharmacists and 15 with junior titles, or 29 percent of the workforce.

The company was assessed by a panel from the Tianjin Science and Technology Commission and admitted to the register of Tianjin high-tech enterprises in 2009. It holds an internet drug information service certificate and operates a further production company, Zhongrui (Inner Mongolia) Pharmaceutical.